A real-world study to determine changes in patient-reported symptoms and quality of life in first year after treatment with axicabtagene ciloleucel
Latest Information Update: 25 Jan 2023
At a glance
- Drugs Axicabtagene ciloleucel (Primary)
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma; Large cell carcinoma
- Focus Therapeutic Use
Most Recent Events
- 25 Jan 2023 New trial record
- 13 Dec 2022 Results presented at the 64th American Society of Hematology Annual Meeting and Exposition